Improved functionality, health related quality of life and decreased burden of disease in patients with ADHD treated with OROS^®MPH: is treatment response different between children and adolescents?

• Asıl Yazarlar: Rettig Klaus (Yazar), Slawik Lara (Yazar), Mattejat Fritz (Yazar), Hargarter Ludger (Yazar), Kordon Andreas (Yazar), Berek Michael (Yazar), Schäuble Barbara (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2011-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

<p>Abstract</p> <p>Background</p> <p>To compare clinical and health-related quality of life (HRQoL) outcomes between children and adolescents with ADHD treated with OROS^®MPH, using data from two large similarly-designed multicenter, prospective,...